SEC Launches Insider-Trading Suit Over $3.3B Abbott Deal
The U.S. Securities and Exchange Commission on Monday hit two Chilean businessmen, including an ex-board member of CFR Pharmaceuticals SA, with a New York federal suit alleging they made $10.6 million...To view the full article, register now.
Already a subscriber? Click here to view full article